譽衡藥業(002437.SZ):子公司一立體倉庫發生火災事故 未有傷亡
格隆匯5月13日丨譽衡藥業(002437.SZ)公佈,2022年5月12日20點50分左右,全資子公司譽衡製藥位於哈爾濱市利民經濟技術開發區北京路29號院內的一個立體倉庫發生火災事故。事故發生後,公司立即啟動應急預案,當地消防部門迅速到場實施救援。經過消防應急等部門的全力撲救,火勢已於當晚23點05分被撲滅。
譽衡製藥此立體倉庫建築面積約1518.43㎡,存放的物品為部分藥品成品及包材,此立體倉庫獨立於生產車間和其他庫房,因此,該次事故未對譽衡製藥生產車間及其他庫房造成影響。該次事故未造成人員傷亡,事故具體原因及造成的損失尚在調查確認中,譽衡製藥將積極配合消防等部門開展後續工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.